(European Society of Cardiology) The antiplatelet drugs prasugrel and ticagrelor had similar safety and efficacy among patients with acute myocardial infarction and ST segment elevations (STEMI), according to results of PRAGUE-18, the first randomized, head-to-head comparison of the drugs.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2c5i7jw
No comments:
Post a Comment